Clinuvel Pharmaceuticals | CUV - Cost Of Sales

Stock Price
9.32
Daily Change
0.31 3.44%
Monthly
-6.80%
Yearly
-7.45%
Q2 Forecast
8.82

Clinuvel Pharmaceuticals reported AUD2.64M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesoblast USD -7.6M 27.47M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025